Form 4 IDEXX LABORATORIES INC For: Jun 01 Filed by: FENNELL GEORGE

Tue, 02 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260602/26592853.html

Form 4 IDEXX LABORATORIES INC For: Jun 01 Filed by: FENNELL GEORGE

Tue, 02 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260602/26592853.html

Form SD IDEXX LABORATORIES INC

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583282.html

Form SD IDEXX LABORATORIES INC

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583282.html

IDEXX adds tapeworm detection to Fecal Dx testing platform

Tue, 26 May 2026 07:01:19 -0400

IDEXX Laboratories Inc. (NASDAQ: IDXX) announced the expansion of its Fecal Dx antigen testing platform to include detection of taeniid tapeworm, including Taenia and Echinococcus species.

The company stated that Fecal Dx antigen testing can detect up to twice as many intestinal parasite infections earlier than fecal flotation alone. Since launching in 2012, more than 50 million Fecal Dx antigen tests have been conducted worldwide.

This marks the third menu expansion in four years for the platform. The addition brings the total number of detected intestinal parasite groups to seven, including hookworm, roundworm, whipworm, flea tapeworm, taeniid tapeworm, Cystoisospora and Giardia in

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

WESTBROOK, Maine--(BUSINESS WIRE)-- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx™ antigen testing platform with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier than fecal flotation alone,1 Fecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care.

This press release features multimedia. View the full release here:

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

This press release features multimedia. View the full release here:

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

This press release features multimedia. View the full release here:

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

This press release features multimedia. View the full release here:

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

This press release features multimedia. View the full release here:

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

This press release features multimedia. View the full release here:

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

This press release features multimedia. View the full release here:

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

This press release features multimedia. View the full release here:

Form 144 IDEXX LABORATORIES INC Filed by: SZOSTAK M ANNE

Wed, 20 May 2026 18:30:00 -0400

si-local-file:///var/storage/secattach/20260520/26529833.html

Form 144 IDEXX LABORATORIES INC Filed by: SZOSTAK M ANNE

Wed, 20 May 2026 18:30:00 -0400

si-local-file:///var/storage/secattach/20260520/26529833.html

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

Tue, 19 May 2026 07:00:00 -0400

Built-in SDMA delivers earlier insights with seamless workflow

WESTBROOK, Maine--(BUSINESS WIRE)-- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that SDMA, a renal biomarker, will be built into Catalyst™ CLIPs, making complete kidney function evaluation part of the most common point-of-care chemistry profiles. Available beginning in June to customers in the United States and Canada, the integration expands access to advanced kidney assessment at scale, enabling veterinarians to identify kidney function loss earlier and act sooner, without disrupting familiar workflows.